US BANCORP \DE\ - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q3 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CUREVAC N V
ValueSharesWeighting
Q3 2023$21,214
-49.6%
3,106
-23.1%
0.00%
Q2 2023$42,066
+63.4%
4,037
+9.3%
0.00%
Q1 2023$25,740
+70.5%
3,693
+47.5%
0.00%
Q4 2022$15,099
+67.8%
2,504
+133.8%
0.00%
Q3 2022$9,000
-85.0%
1,071
-75.7%
0.00%
Q2 2022$60,000
-62.3%
4,404
-45.8%
0.00%
Q1 2022$159,000
-37.9%
8,123
+8.9%
0.00%
Q4 2021$256,000
-11.4%
7,458
+40.5%
0.00%
-100.0%
Q3 2021$289,0005,3080.00%
Other shareholders
CUREVAC N V shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 3,134,780$107,600,00032.65%
Affinity Asset Advisors, LLC 50,000$1,716,0000.62%
Renaissance Capital LLC 21,659$743,0000.19%
Eversept Partners, LP 85,017$2,916,9330.19%
TWINBEECH CAPITAL LP 67,504$2,316,0000.13%
Alpine Global Management, LLC 23,033$790,0000.12%
Paradigm Financial Advisors, LLC 13,535$464,0000.10%
Caption Management, LLC 200,000$6,860,0000.08%
Baillie Gifford 3,923,340$134,610,0000.07%
Donoghue Forlines LLC 11,570$397,0000.07%
View complete list of CUREVAC N V shareholders